D Weycker, A Moynahan, A Silvia, R Sato - PharmacoEconomics-Open, 2021 - Springer
Background While much is known about the cost of community-acquired pneumonia (CAP)
during the acute phase of illness, little is known about the potential attributable cost of CAP …